Geriatrics (Oct 2020)

Protein Ingredient in Saliva on Oral Dryness Patients Caused by Calcium Blocker

  • Fumi Mizuhashi,
  • Takao Morita,
  • Shuji Toya,
  • Ritsuko Sato,
  • Yuko Watarai,
  • Kaoru Koide

DOI
https://doi.org/10.3390/geriatrics5040070
Journal volume & issue
Vol. 5, no. 4
p. 70

Abstract

Read online

Oral dryness as a side effect of certain drugs is increasing. The aim of this study was to examine the change of the protein ingredient in saliva of oral dryness patients caused by calcium blocker. Six patients taking calcium blocker and six healthy elderly were enrolled. Unstimulated salivary flow rate, protein concentration, and flow rate of protein were measured and compared between the patients taking calcium blocker and healthy elderly. iTRAQ (Isobaric Tag for Relative and Absolute Quantitation) proteomic analysis was performed to extract the salivary protein changed in patient taking calcium blocker, and the intensities of Western blotting products were quantified (unpaired t-test). Unstimulated salivary flow rate was significantly lower on patients taking calcium blocker (p p < 0.01). The results of this study indicated that calmodulin-like protein 3 increased in patients taking calcium blocker and could be a salivary biomarker for oral dryness caused by calcium blocker.

Keywords